Trials / Recruiting
RecruitingNCT06588998
Xengenic Cortical Membranes Versus Connective Tissue Graft With Coronally Advanced Flap for the Treatment of Peri-implant Soft Tissue Dehiscences: A Randomized, Controlled Clinical Trial
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Amr Anwar Mohamed Ellithy Yousef · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Peri-implant soft tissue dehiscences represent a common complication in implant dentistry, often leading to esthetic and functional challenges. Current treatment options, including Xengenic cortical membranes and connective tissue graft with coronally advanced flap, aim to promote soft tissue regeneration and improve clinical outcomes. However, there is a need for comparative studies to determine the optimal treatment modality for peri-implant soft tissue dehiscences.
Detailed description
Aim: Comparing the effectiveness and patient outcomes of Xengenic cortical membranes versus connective tissue graft with coronally advanced flap for the treatment of peri-implant soft tissue dehiscences.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Xengenic Cortical membranes | soft tissue surgery around dental implant dehiscence |
| PROCEDURE | connective tissue graft | soft tissue surgery around dental implant dehiscence |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-30
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Egypt
Regulatory
- FDA-regulated drug study
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06588998. Inclusion in this directory is not an endorsement.